Anti-SLC39A7 monoclonal antibody

Pre-made anti-SLC39A7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC39A7/SLC39A7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1738-Ab-1/ GM-Tg-hg-IP1738-Ab-2Anti-Human SLC39A7 monoclonal antibodyHuman
GM-Tg-rg-IP1738-Ab-1/ GM-Tg-rg-IP1738-Ab-2Anti-Rat SLC39A7 monoclonal antibodyRat
GM-Tg-mg-IP1738-Ab-1/ GM-Tg-mg-IP1738-Ab-2Anti-Mouse SLC39A7 monoclonal antibodyMouse
GM-Tg-cynog-IP1738-Ab-1/ GM-Tg-cynog-IP1738-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC39A7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1738-Ab-1/ GM-Tg-felg-IP1738-Ab-2Anti-Feline SLC39A7 monoclonal antibodyFeline
GM-Tg-cang-IP1738-Ab-1/ GM-Tg-cang-IP1738-Ab-2Anti-Canine SLC39A7 monoclonal antibodyCanine
GM-Tg-bovg-IP1738-Ab-1/ GM-Tg-bovg-IP1738-Ab-2Anti-Bovine SLC39A7 monoclonal antibodyBovine
GM-Tg-equg-IP1738-Ab-1/ GM-Tg-equg-IP1738-Ab-2Anti-Equine SLC39A7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1738-Ab-1/ GM-Tg-hg-IP1738-Ab-2; GM-Tg-rg-IP1738-Ab-1/ GM-Tg-rg-IP1738-Ab-2;
GM-Tg-mg-IP1738-Ab-1/ GM-Tg-mg-IP1738-Ab-2; GM-Tg-cynog-IP1738-Ab-1/ GM-Tg-cynog-IP1738-Ab-2;
GM-Tg-felg-IP1738-Ab-1/ GM-Tg-felg-IP1738-Ab-2; GM-Tg-cang-IP1738-Ab-1/ GM-Tg-cang-IP1738-Ab-2;
GM-Tg-bovg-IP1738-Ab-1/ GM-Tg-bovg-IP1738-Ab-2; GM-Tg-equg-IP1738-Ab-1/ GM-Tg-equg-IP1738-Ab-2
Products NameAnti-SLC39A7 monoclonal antibody
Formatmab
Target NameSLC39A7
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC39A7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1738-Ag-1Recombinant multi-species S39A7/ SLC39A7/ D6S115E protein
    ORF Viral VectorvGMLP003777human SLC39A7 Lentivirus particle
    ORF Viral VectorpGMLP003777human SLC39A7 Lentivirus plasmid
    ORF Viral VectorpGMLPm005437mouse Slc39a7 Lentivirus plasmid
    ORF Viral VectorvGMLPm005437mouse Slc39a7 Lentivirus particle


    Target information

    Target IDGM-IP1738
    Target NameSLC39A7
    Gene ID7922,14977,294281,100430704,481736,101086060,540716,100061379
    Gene Symbol and SynonymsAGM9,D6S115E,D6S2244E,H-2Ke4,H2-KE4,HKE4,Ke-4,KE4,RING5,RT1-Ke4,Rt1Ke4,SLC39A7,ZIP7
    Uniprot AccessionQ92504,Q6MGB4,Q5TJF6
    Uniprot Entry NameS39A7_HUMAN,Q6MGB4_RAT,S39A7_CANLF
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000112473
    Target ClassificationN/A

    The target: SLC39A7, gene name: SLC39A7, also named as D6S115E, D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7. The protein encoded by this gene transports zinc from the Golgi and endoplasmic reticulum to the cytoplasm. This transport may be important for activation of tyrosine kinases, some of which could be involved in cancer progression. Therefore, modulation of the encoded protein could be useful as a therapeutic agent against cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.